Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
4.220
-0.190 (-4.31%)
At close: Apr 28, 2026, 4:00 PM EDT
4.220
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:00 PM EDT

Aclaris Therapeutics Market Cap

Aclaris Therapeutics has a market cap or net worth of $586.56 million as of April 28, 2026. Its market cap has increased by 403.26% in one year.

Market Cap
586.56M
Enterprise Value
441.48M
1-Year Change
403.26%
Ranking
Category
Stock Price
$4.22

Market Cap Chart

Since October 7, 2015, Aclaris Therapeutics's market cap has increased from $214.45M to $586.56M, an increase of 173.51%. That is a compound annual growth rate of 10.00%.

History

DateMarket Cap% Change
Apr 27, 2026612.97M87.96%
Dec 31, 2025326.12M22.88%
Dec 31, 2024265.41M256.83%
Dec 29, 202374.38M-92.92%
Dec 30, 20221.05B17.97%
Dec 31, 2021890.25M220.59%
Dec 31, 2020 Pro Pro
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
First Tracks Biotherapeutics 631.04M
Absci 602.90M
Zevra Therapeutics 595.88M
Adlai Nortye 592.00M
ProKidney 585.80M
Shattuck Labs 585.00M
CorMedix 581.94M
Prothena Corporation 578.70M
Market Cap Rankings